This book presents the latest advancements in Continuous Glucose Monitoring (CGM), offering a focused and practical guide for clinicians to effectively prescribe, interpret, and integrate CGM data into patient care.
With an emphasis on recent developments, it delivers essential insights into emerging CGM technologies, accuracy metrics, and clinical applications. Continuous Glucose Monitors: A Guide for Primary Care Clinicians:
Covers the most recent Continuous Glucose Monitoring devices, including over-the-counter options, and their clinical implications
Examines accuracy metrics such as MARD, PARD, and error grids for improved data interpretation
Provides guidance on billing, coding, and insurance considerations to streamline clinical implementation
Explores CGM efficacy across different populations, including athletes, elderly patients, and individuals with gestational diabetes
Discusses barriers to adoption, disparities in access, and the future of CGM technology.
This book will be beneficial for graduate and postgraduate students, clinicians, researchers, healthcare professionals, and academicians in the fields of endocrinology, diabetes management, biomedical engineering, and clinical practice.
Sprache
Verlagsort
Verlagsgruppe
Zielgruppe
Für höhere Schule und Studium
Postgraduate and Undergraduate Advanced
Produkt-Hinweis
Fadenheftung
Gewebe-Einband
Illustrationen
8 s/w Photographien bzw. Rasterbilder, 14 s/w Zeichnungen, 22 s/w Tabellen, 22 s/w Abbildungen
22 Tables, black and white; 14 Line drawings, black and white; 8 Halftones, black and white; 22 Illustrations, black and white
Maße
Höhe: 234 mm
Breite: 156 mm
ISBN-13
978-1-041-10653-1 (9781041106531)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Klassifikation
Laura Solano teaches genetics at A.T. Still University, USA. She graduated from the University of North Texas Health Sciences with a master's in physician assistant studies. She has practiced faithfully in primary care for over a decade. In 2022, she graduated from A.T. Still University with a Doctorate in Medical Sciences and has published several research and education articles
Contents
Preface.......................................................................................................................ix
Acknowledgments......................................................................................................x
Chapter 1 History of CGMs..................................................................................1
Chapter 2 Technology .........................................................................................10
Chapter 3 Accuracy.............................................................................................17
Chapter 4 Data Interpretation and Ambulatory Glucose Profile .........................25
Chapter 5 OTC CGMs ........................................................................................32
Chapter 6 Prescription CGM Indications............................................................36
Chapter 7 Efficacy...............................................................................................39
Chapter 8 Billing and Coding .............................................................................46
Chapter 9 Adverse Effects and Interfering Substances.......................................52
Chapter 10 Adoption and Barriers........................................................................56
Chapter 11 Disparities...........................................................................................62
Chapter 12 Insurance Coverage Complexities......................................................64
Chapter 13 Privacy of CGM Data.........................................................................66
Chapter 14 AI + CGM ..........................................................................................70
Chapter 15 Fitness, Athletes, and CGMs..............................................................73
Chapter 16 Research on Psychiatric Effects of CGMs.........................................77
Chapter 17 Controversy ........................................................................................79
Chapter 18 Case Studies .......................................................................................81
Chapter 19 Future Directions................................................................................85
Index........................................................................................................................89
